HYDERABAD, India鈥� Aurigene Pharmaceutical Services, an integrated drug discovery and CDMO partner and subsidiary of Dr. Reddy鈥檚 Laboratories, today announced progress in its research collaboration with Alveus Therapeutics, a biotechnology company developing next-generation therapies for obesity and metabolic diseases.
Under the collaboration, Aurigene provides integrated drug discovery services supporting Alveus鈥� research programs in metabolic disease. It combines Alveus鈥� expertise in metabolic biology and therapeutic strategy with Aurigene鈥檚 discovery capabilities, including computational design, medicinal chemistry, and integrated biology platforms.
The teams nominated ALV-200, a highly selective AMYR3 peptide candidate for metabolic disorders, as the first development candidate. The candidate is part of Alveus鈥� broader portfolio of next-generation therapies being developed for obesity and metabolic disease.
Additional discovery programs are ongoing as part of the collaboration supporting Alveus鈥� expanding research portfolio.
Discovery efforts are supported by Aurigene.AI, Aurigene鈥檚 AI-enabled drug discovery platform integrating generative design, predictive modeling, and computational chemistry with high-throughput laboratory capabilities to support efficient design-make-test cycles.
鈥淭his collaboration reflects Aurigene鈥檚 ability to support innovative biotechnology companies with integrated discovery capabilities across computational and experimental platforms,鈥� said Akhil Ravi, chief executive officer at Aurigene Pharmaceutical Services. 鈥淲e are pleased to contribute our expertise to programs aimed at addressing important unmet needs in metabolic disease.鈥�
鈥淲e selected Aurigene for their strong discovery capabilities and integrated platform supporting peptide and small molecule research,鈥� said Jacob Jeppesen, chief scientific officer and Head of R&D at Alveus Therapeutics. 鈥淭heir team has been an important contributor to advancing several of our discovery programs, including the nomination of ALV-200.鈥�
